Moderna Inc.

Moderna, Inc. (https://www.modernatx.com/) is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, and systemic intracellular therapeutics.

• Romania, cea mai ridicata rata a inflatiei din UE - 23 februarie 2024
• Vanzari in crestere in comertul cu amanuntul - 07 septembrie 2023
• Piata asigurarilor, in crestere - 05 mai 2023
• 📉 Indicele DJIA: a 2-a saptamana consecutiva pe minus
• Indicele DJIA: a 4-a zi consecutiva pe minus
• Romanii - mai atenti cu becurile aprinse - 15 decembrie 2022
• Vaccine maker stocks rise as China battles worst Covid outbreak since 2020 - 15 martie 2022
• Vaccine inequity will cost the world trillions of dollars, WHO Foundation warns (US.MRNA) (US.PFE) - 16 martie 2022
• SUA comanda 3.2 milioane de doze de vaccin Novavax COVID - 11 iulie 2022
• Pro Kevin O'Leary names 3 companies to invest in: These are 'not going to zero' - 20 iunie 2022